North America Hormone Replacement Therapy Market Size & Outlook
North America hormone replacement therapy market, 2018-2030 (US$M)
Related Markets
North America hormone replacement therapy market highlights
- The North America hormone replacement therapy market generated a revenue of USD 8,330.0 million in 2022.
- The market is expected to grow at a CAGR of 6.3% from 2023 to 2030.
- In terms of segment, estrogen and progesterone replacement therapy was the largest revenue generating product in 2022.
- Parathyroid Hormone replacement is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2023 to 2030.
North America data book summary
| Market revenue in 2022 | USD 8,330.0 million |
| Market revenue in 2030 | USD 13,582.5 million |
| Growth rate | 6.3% (CAGR from 2022 to 2030) |
| Largest segment | Estrogen and progesterone replacement therapy |
| Fastest growing segment | Parathyroid Hormone replacement |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Estrogen and Progesterone Replacement Therapy, HGH replacement therapy, Thryoid hormone replacement therapy, Testosterone Replacement Therapy, Parathyroid Hormone replacement |
| Key market players worldwide | Eli Lilly and Co, Bayer AG, Hisamitsu Pharmaceutical Co Inc, Pfizer Inc, Merck & Co Inc, Viatris Inc, Novo Nordisk A/S ADR, AbbVie Inc, Roche Holding AG ADR, Ascend Wellness Holdings Inc |
Other key industry trends
- In terms of revenue, North America region accounted for 39.1% of the global hormone replacement therapy market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 8,431.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hormone Replacement Therapy Market Scope
Hormone Replacement Therapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America hormone replacement therapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hormone replacement therapy market will help companies and investors design strategic landscapes.
Estrogen and progesterone replacement therapy was the largest segment with a revenue share of 54.69% in 2022. Horizon Databook has segmented the North America hormone replacement therapy market based on estrogen and progesterone replacement therapy, hgh replacement therapy, thryoid hormone replacement therapy, testosterone replacement therapy, parathyroid hormone replacement covering the revenue growth of each sub-segment from 2018 to 2030.
North America accounted for the largest share in 2021. Technological advancements, major product launches, collaborative agreements between manufacturers, easy accessibility of quality medical facilities, and favorable reimbursement policies are among factors responsible for the largest market share held by the region.
The healthcare system in North America relies mostly on the government to provide healthcare services and health insurance. The active involvement of the government to provide quality and ease of such services make the U.S. and Canada prominent markets. The prevalence of hormonal disorders is moderately high in this region.
Growth Hormone Deficiency (GHD) in the region ranges from one in 4,000 to one in 10,000 people. In adults, the incidence of GHD is estimated to be around one in 100,000, whereas, in children, the incidence of GHD is approximately two in 100,000 annually. About 15% to 20% of pediatric cases show disease transition into adulthood.
Reasons to subscribe to North America hormone replacement therapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America hormone replacement therapy market databook
-
Our clientele includes a mix of hormone replacement therapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America hormone replacement therapy market , including forecasts for subscribers. This continent databook contains high-level insights into North America hormone replacement therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America hormone replacement therapy market size, by country, 2018-2030 (US$M)
North America Hormone Replacement Therapy Market Outlook Share, 2022 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
